VAERS reports by lot

Pfizer COVID-19 lot EWO217: VAERS reports

36 VAERS reports list lot EWO217 as a Pfizer COVID-19 vaccine, received between 2021-06-06 and 2022-03-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
36
Reports
19%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological2922%
Musculoskeletal2217%
General / Systemic (non-local)1814%
Gastrointestinal1310%
Cardiac / Cardiovascular108%
Respiratory97%
Dermatological (non-injection-site)97%
Thrombotic / Hematological86%
Injection-site / Local reaction65%
Allergic / Anaphylactic43%
Psychiatric / Neuropsychiatric22%
Reproductive / Menstrual22%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York6
California4
Illinois2
New Jersey2
Nebraska2
Virginia2
Oregon2
Minnesota2
Massachusetts1
Texas1
Michigan1
West Virginia1

Reports by month received

2021-068
2021-075
2021-087
2021-092
2021-102
2021-114
2021-121
2022-011
2022-023
2022-033

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.